SCHEMBL4053006

SCHEMBL4053006

NC(=O)c1nc(-c2cccnc2)nc(Nc2ccccc2)c1N

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.57
CYP1A2 P05177 3/20 0.57
TSHR P16473 2/20 0.57
ALDH1A1 P00352 2/20 0.57
LMNA P02545 2/20 0.57
USP2 O75604 1/20 0.57
CLK4 Q9HAZ1 1/20 0.57
L3MBTL1 Q9Y468 1/20 0.52
MAPT P10636 5/20 0.51
KDM4E B2RXH2 4/20 0.51
MAPK1 P28482 2/20 0.51
CYP2C19 P33261 2/20 0.51
HPGD P15428 2/20 0.51
HSD17B10 Q99714 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
ADORA3 P0DMS8 1/20 0.51
ABCG2 Q9UNQ0 6/20 0.49
HTT P42858 2/20 0.49
NPSR1 Q6W5P4 2/20 0.48
CYP2D6 P10635 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4229755 0.87 ABCG2 (0.59) CYP3A4CYP1A2TSHRALDH1A1LMNA
SCHEMBL28819383 0.81 CYP1A2 (0.55) CYP3A4CYP1A2TSHRALDH1A1LMNA
SCHEMBL28819378 0.81 CYP1A2 (0.54) CYP3A4CYP1A2TSHRALDH1A1LMNA
SCHEMBL27796437 0.80 CYP1A2 (0.62) CYP3A4CYP1A2TSHRALDH1A1LMNA
SCHEMBL7280796 0.73 CYP1A2 (1.00) CYP3A4CYP1A2TSHRALDH1A1LMNA
SCHEMBL16388467 0.71 TSHR (0.57) CYP3A4CYP1A2TSHRALDH1A1LMNA
SCHEMBL4053003 0.71 MAPK8 (0.47) CYP3A4CYP1A2TSHRALDH1A1LMNA
SCHEMBL29961476 0.70 MKNK1 (0.54) CYP3A4CYP1A2ALDH1A1LMNAMAPT
SCHEMBL12287874 0.70 MAPT (0.51) CYP3A4ALDH1A1LMNAMAPTKDM4E
SCHEMBL14726035 0.69 CYP1A2 (0.63) CYP3A4CYP1A2TSHRALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101679432-B Heteroaryl compounds, compositions thereof, and their use as protein kinase inhibitors SIGNAL PHARM LLC 2015-04-22 CN disclosed
EP-2078018-A1 HETEROARYL COMPOUNDS, COMPOSITIONS THEREOF, AND USE THEREOF AS PROTEIN KINASE INHIBITORS Signal Pharmaceuticals LLC (US) 2009-07-15 EP disclosed
WO-2008051494-A1 HETEROARYL COMPOUNDS, COMPOSITIONS THEREOF, AND USE THEREOF AS PROTEIN KINASE INHIBITORS SIGNAL PHARMACEUTICALS, LLC (US) 2008-05-02 WO disclosed